Paper40329432
Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care.
Crutzen S and 8 others. Schizophr Bull, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care. Papers, record 40329432. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40329432
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Trends in Antipsychotic Polypharmacy and Potential Overtreatment with Antipsychotics: A Naturalistic Cohort Study of People in Long-term Care.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antipsychotic Agents | Major topic |
| Polypharmacy | Major topic |
| Long-Term Care | Major topic |
| Medical Overuse | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Longitudinal Studies | |
| Aged | |
| Adult | |
| Sweden | |
| Cohort Studies |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23936389 | Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials. | PLoS One | 2013 | https://conductscience.org/library/papers/23936389 | PubMed |
| 2 | 30862219 | Antipsychotic treatment - a systematic literature review and meta-analysis of qualitative studies. | J Ment Health | 2020 | https://conductscience.org/library/papers/30862219 | PubMed |
| 3 | 26256007 | Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study. | Eur Neuropsychopharmacol | 2015 | https://conductscience.org/library/papers/26256007 | PubMed |
| 4 | 28237639 | Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. | Lancet Psychiatry | 2017 | https://conductscience.org/library/papers/28237639 | PubMed |
| 5 | 28735640 | Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method. | Schizophr Res | 2018 | https://conductscience.org/library/papers/28735640 | PubMed |
| 6 | 34126462 | Factors predicting high-dose and combined antipsychotic prescribing in New Zealand: High-dose antipsychotic prescribing. | Psychiatry Res | 2021 | https://conductscience.org/library/papers/34126462 | PubMed |
| 7 | 34406325 | Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis. | JAMA Psychiatry | 2021 | https://conductscience.org/library/papers/34406325 | PubMed |
| 8 | 31182319 | Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis. | Schizophr Res | 2019 | https://conductscience.org/library/papers/31182319 | PubMed |
| 9 | 15741458 | Remission in schizophrenia: proposed criteria and rationale for consensus. | Am J Psychiatry | 2005 | https://conductscience.org/library/papers/15741458 | PubMed |
| 10 | 35524619 | Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. | World Psychiatry | 2022 | https://conductscience.org/library/papers/35524619 | PubMed |
| 11 | 29856543 | What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? | World Psychiatry | 2018 | https://conductscience.org/library/papers/29856543 | PubMed |
| 12 | 32867516 | The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia. | Am J Psychiatry | 2020 | https://conductscience.org/library/papers/32867516 | PubMed |
| 13 | 17012982 | Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries. | Int Clin Psychopharmacol | 2006 | https://conductscience.org/library/papers/17012982 | PubMed |
| 14 | 30785608 | Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia. | JAMA Psychiatry | 2019 | https://conductscience.org/library/papers/30785608 | PubMed |
| 15 | 33417992 | Dose-dependent effects of antipsychotics on efficacy and adverse effects in schizophrenia. | Behav Brain Res | 2021 | https://conductscience.org/library/papers/33417992 | PubMed |
| 16 | 19133060 | High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies. | Br J Clin Pharmacol | 2009 | https://conductscience.org/library/papers/19133060 | PubMed |
| 17 | 20360319 | International consensus study of antipsychotic dosing. | Am J Psychiatry | 2010 | https://conductscience.org/library/papers/20360319 | PubMed |
| 18 | 29387876 | Mortality Rates After the First Diagnosis of Psychotic Disorder in Adolescents and Young Adults. | JAMA Psychiatry | 2018 | https://conductscience.org/library/papers/29387876 | PubMed |
| 19 | 24923760 | Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China. | Aust N Z J Psychiatry | 2015 | https://conductscience.org/library/papers/24923760 | PubMed |
| 20 | 31838873 | Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. | Am J Psychiatry | 2020 | https://conductscience.org/library/papers/31838873 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42447169 | Psychiatric nurses versus psychiatrists and pharmacists 'knowledge on polypharmacy practices in psychiatry: An interprofessional mixed-methods exploration. | PLoS One | 2026 | https://conductscience.org/library/papers/42447169 | PubMed |
| 40801808 | The Association of Antipsychotic Treatment and Side Effects With Societal Recovery and Happiness: A Naturalistic Cohort Study of People in Long-term Care for a Psychotic Disorder. | Schizophr Bull | 2026 | https://conductscience.org/library/papers/40801808 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40329432
GET https://conductscience.org/api/papers/v1/40329432/references?page=2